StimCell Enegetics Inc
stimcell.comWhat Do They Do?
Develops microcurrent therapy devices for healthcare professionals and patients, designed to support general wellness and provide temporary pain relief.
10-K for FY2026, filed Aug 31, 2026
Who Are Their Customers?
The eBalance Pro is designed for healthcare professionals in clinical settings, while eBalance Home is for patients to use at home. Live Current Media held worldwide end-user distribution rights before the company reacquired them.
10-K for FY2026, filed Aug 31, 2026The Company acquired its proprietary microcurrent technology designed to be used in the treatment of diabetes and related ailments (the…View ↗
Marketing PlansView ↗
On January 29, 2020, the Company reacquired the Direct Rights from LIVC in exchange for a royalty on all sales of the eBalance® device up…View ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q1 FY2027, filed Oct 14, 2026
−$169.5KView ↗
- ▼ −36% (Loss)
- vs −$265.6K in Q1 FY2026
Home device redesign
The latest report describes plans to redesign eBalance Home as a smaller, lower-cost consumer device with diagnostic features, including real-time cellular-energy assessment, treatment tracking and user profiles; the older report described a home system for patient use.
10-K for FY2023, filed Sep 1, 2023 10-K for FY2026, filed Aug 31, 2026eBalance® Technology is intended to expand the traditional healthcare model of managing various pathological diseases and ailments, such as…View ↗
Who Do They Compete With?
Competes with Bayer, Becton Dickinson, LifeScan, MediSense, and TheraSense
10-K for FY2026, filed Aug 31, 2026The market for treatment and management of diabetes and related ailments is intensely competitive, subject to rapid change and…View ↗
Loading...
